SANKOMBI D 5 drops, arteriosclerosis, apoplexy, embolism, glaucoma
Homeopathic medicine SANKOMBI D 5, arteriosclerosis, apoplexy, embolism, glaucoma.
active SANKOMBI D 5, arteriosclerosis, apoplexy, embolism, glaucoma ingredients
- 0.5 ml Mucor racemosus e volumine mycelii (lyophil., sterile.) D5
- 0.5 ml Aspergillus niger e volumine mycelii (lyophil., sterile.) D5
Mucor racemosus benefits:
This remedy is used to treat pathological disruptions in the arterial and venous system, circulatory disturbances, arteriosclerosis, apoplexy (stroke), embolisms, glaucoma, varicose veins, thromboses, diabetic gangrene, phlebitis, hemorrhoids and constipation.
Aspergillus niger benefits:
Aspergillus niger is more prevalent in warmer climates, both in field situations and stored foods. The black spores apparently provide protection from sunlight and UV irradiation, providing a competitive advantage in such habitats.
SANKOMBI D 5, arteriosclerosis, apoplexy, embolism, glaucoma excipients
- water, purified
Drops for oral use and rubbing in
Mucor racemosus D5, Aspergillus niger D5
10 ml liquid dilution contain:
5 ml Mucor racemosus e volumine mycelii Dil. D5 (HAB, regulation 5a; solution D1 with purified water).
5 ml Aspergillus niger e volumine mycelii dil. D5 (HAB, regulation 5a; solution D1 with purified water).
Experience has shown that it is used for:
Registered homeopathic medicinal product, therefore no therapeutic indication is given.
For oral use:
Adults and adolescents from the age of 12 take 5 drops 1-2 times a day.
For rubbing in:
Adults and young people from the age of 12 rub 5-10 drops into the crook of the arm once a day. After a maximum of 4 weeks of therapy, Sankombi® D5 should be discontinued.
Due to the content of specific organic components in Sankombi® D5, hypersensitivity reactions, mainly in the form of skin reactions, can occur in rare cases and an allergy to the components Aspergillus niger and Mucor racemosus can be triggered. The drug should then be discontinued and a doctor consulted.
Do not use with:
- Known hypersensitivity to mold (Aspergillus niger/ Mucor racemosus)
- autoimmune diseases
- children under 12 years of age
- pregnant and lactating women
Drugs with an immunosuppressive effect can impair the effectiveness of Sankombi® D5. An interval of 4 weeks should be observed before and after treatment with orally administered live vaccines.
Additional information :
In isopathic therapy, Sankombi® D5 is used as an adjunctive therapy for all chronic diseases that are based on an endobiosis disorder. This can be caused by a congestion disease or a tuberculin constitution.